John Thomas Burns
Senior VP & CFOMr. John Thomas Burns, CPA, served as Senior Vice President of Finance at SELLAS Life Sciences Group, Inc. since January 2022 until February 02, 2023 and serves as its Chief Financial Officer since February 02, 2023 and served as Principal Accounting Officer since February 02, 2023 and served as its Chief Accounting Officer since January 29, 2021 until February 2023 and serves as its Senior Vice President. He served as Vice President of Finance and Corporate Controller at SELLAS Life Sciences Group, Inc. since December 2017 and served as its Interim Principal Accounting Officer since December 17, 2018 until January 29, 2021. He joined SELLAS Life Sciences Group, Inc. in May 2013 and has held various positions of increasing responsibility during his tenure, including his current position of Vice President, Finance and Corporate Controller which he has held since December 30, 2017. He was Vice President of Finance at Galena Biopharma, Inc. since August 8, 2016 and has been its Controller since June 2015 and served as its Principal Accounting Officer from February 23, 2016 to August 8, 2016. Prior to Galena, he served as a Securities and Exchange Commission (SEC) Reporting Manager at Pixelworks, Inc., a company focused on video display processing technology. He began his career in public accounting at Moss Adams LLP where he worked with private and public technology companies providing business assurance services. He served as Advisory Board Member for Novate Medical Technologies and currently offers financial and market guidance to a private, medical device start-up company. He holds a Master of Accounting and a B. S. M. in Finance from Tulane University. He is an active Certified Public Accountant.
Positions
- Company NameSELLAS Life Sciences Group, Inc.Stock CodeSLSPositionSenior VP & CFOColleagues
- AMAngelos M. StergiouFounder, President, CEO & Director
- JWJohn W. VarianIndependent Chairman of Board
- DCDragan CicicSenior VP & Chief Development Officer
- SEStacy E. YeungVP, General Counsel & Corporate Secretary
- AEAndrew ElnatanSenior VP of Regulatory Affairs, CMC & Quality
- JWJane WasmanIndependent Director
- RLRobert L. Van NostrandIndependent Director
- KBKatherine Bach KalinIndependent Director
